Diffuse large B-cell lymphoma Trials in London, United Kingdom
Conditions / Diffuse large B-cell lymphoma / London, United Kingdom
Diffuse large B-cell lymphoma has been the subject of sustained clinical investigation across multiple research sites.
40 total trials for this combination
Showing top 10 of 40 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03000192 | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | UNKNOWN | — |
| NCT03274492 | A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02793583 | Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma | TERMINATED | PHASE2/PHASE3 |
| NCT04824092 | Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01804686 | A Long-term Extension Study of PCI-32765 (Ibrutinib) | RECRUITING | PHASE3 |
| NCT05578976 | A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04104776 | A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas | RECRUITING | PHASE1/PHASE2 |
| NCT01177397 | Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma | COMPLETED | PHASE1/PHASE2 |
| NCT04254107 | A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer | TERMINATED | PHASE1 |
| NCT02952508 | Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia | ACTIVE_NOT_RECRUITING | PHASE2 |